1. Home
  2. LXRX vs LWAY Comparison

LXRX vs LWAY Comparison

Compare LXRX & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • LWAY
  • Stock Information
  • Founded
  • LXRX 1995
  • LWAY 1986
  • Country
  • LXRX United States
  • LWAY United States
  • Employees
  • LXRX N/A
  • LWAY N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • LWAY Packaged Foods
  • Sector
  • LXRX Health Care
  • LWAY Consumer Staples
  • Exchange
  • LXRX Nasdaq
  • LWAY Nasdaq
  • Market Cap
  • LXRX 428.8M
  • LWAY 513.4M
  • IPO Year
  • LXRX 2000
  • LWAY 1987
  • Fundamental
  • Price
  • LXRX $1.09
  • LWAY $33.82
  • Analyst Decision
  • LXRX Buy
  • LWAY Buy
  • Analyst Count
  • LXRX 5
  • LWAY 2
  • Target Price
  • LXRX $3.23
  • LWAY $33.00
  • AVG Volume (30 Days)
  • LXRX 1.6M
  • LWAY 71.8K
  • Earning Date
  • LXRX 11-11-2025
  • LWAY 11-13-2025
  • Dividend Yield
  • LXRX N/A
  • LWAY N/A
  • EPS Growth
  • LXRX N/A
  • LWAY N/A
  • EPS
  • LXRX N/A
  • LWAY 0.70
  • Revenue
  • LXRX $58,432,000.00
  • LWAY $193,021,000.00
  • Revenue This Year
  • LXRX N/A
  • LWAY $14.66
  • Revenue Next Year
  • LXRX N/A
  • LWAY $13.81
  • P/E Ratio
  • LXRX N/A
  • LWAY $48.34
  • Revenue Growth
  • LXRX 1504.83
  • LWAY 9.19
  • 52 Week Low
  • LXRX $0.28
  • LWAY $19.50
  • 52 Week High
  • LXRX $2.18
  • LWAY $34.20
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 47.78
  • LWAY 72.19
  • Support Level
  • LXRX $1.03
  • LWAY $32.42
  • Resistance Level
  • LXRX $1.19
  • LWAY $32.85
  • Average True Range (ATR)
  • LXRX 0.06
  • LWAY 1.17
  • MACD
  • LXRX -0.00
  • LWAY 0.12
  • Stochastic Oscillator
  • LXRX 35.29
  • LWAY 93.27

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

Share on Social Networks: